Ming-Chung Jiang

CEO , TargeTrust Biotech. Ltd.

Ming-Chung  Jiang

Speaker Bio

At TargeTrust Biotech, we offer a product that can detect cancer therapy resistance in real-time which cannot be achieved by current methods such as CT, MRI, PET, tissue biopsy, and Next Generation DNA Sequencing. Our Tumor Signal Transduction-Liquid Biopsy method helps patients get the correct drug in time.

Email:[email protected]